Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 80.61 USD 2.58% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
Transmedics Group Inc?
Write Note

Intrinsic Value

The intrinsic value of one TMDX stock under the Base Case scenario is 46.31 USD. Compared to the current market price of 80.61 USD, Transmedics Group Inc is Overvalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TMDX Intrinsic Value
46.31 USD
Overvaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Transmedics Group Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TMDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TMDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Transmedics Group Inc

Provide an overview of the primary business activities
of Transmedics Group Inc.

What unique competitive advantages
does Transmedics Group Inc hold over its rivals?

What risks and challenges
does Transmedics Group Inc face in the near future?

Has there been any significant insider trading activity
in Transmedics Group Inc recently?

Summarize the latest earnings call
of Transmedics Group Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Transmedics Group Inc.

Provide P/S
for Transmedics Group Inc.

Provide P/E
for Transmedics Group Inc.

Provide P/OCF
for Transmedics Group Inc.

Provide P/FCFE
for Transmedics Group Inc.

Provide P/B
for Transmedics Group Inc.

Provide EV/S
for Transmedics Group Inc.

Provide EV/GP
for Transmedics Group Inc.

Provide EV/EBITDA
for Transmedics Group Inc.

Provide EV/EBIT
for Transmedics Group Inc.

Provide EV/OCF
for Transmedics Group Inc.

Provide EV/FCFF
for Transmedics Group Inc.

Provide EV/IC
for Transmedics Group Inc.

Show me price targets
for Transmedics Group Inc made by professional analysts.

What are the Revenue projections
for Transmedics Group Inc?

How accurate were the past Revenue estimates
for Transmedics Group Inc?

What are the Net Income projections
for Transmedics Group Inc?

How accurate were the past Net Income estimates
for Transmedics Group Inc?

What are the EPS projections
for Transmedics Group Inc?

How accurate were the past EPS estimates
for Transmedics Group Inc?

What are the EBIT projections
for Transmedics Group Inc?

How accurate were the past EBIT estimates
for Transmedics Group Inc?

Compare the revenue forecasts
for Transmedics Group Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Transmedics Group Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Transmedics Group Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Transmedics Group Inc compared to its peers.

Compare the P/E ratios
of Transmedics Group Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Transmedics Group Inc with its peers.

Analyze the financial leverage
of Transmedics Group Inc compared to its main competitors.

Show all profitability ratios
for Transmedics Group Inc.

Provide ROE
for Transmedics Group Inc.

Provide ROA
for Transmedics Group Inc.

Provide ROIC
for Transmedics Group Inc.

Provide ROCE
for Transmedics Group Inc.

Provide Gross Margin
for Transmedics Group Inc.

Provide Operating Margin
for Transmedics Group Inc.

Provide Net Margin
for Transmedics Group Inc.

Provide FCF Margin
for Transmedics Group Inc.

Show all solvency ratios
for Transmedics Group Inc.

Provide D/E Ratio
for Transmedics Group Inc.

Provide D/A Ratio
for Transmedics Group Inc.

Provide Interest Coverage Ratio
for Transmedics Group Inc.

Provide Altman Z-Score Ratio
for Transmedics Group Inc.

Provide Quick Ratio
for Transmedics Group Inc.

Provide Current Ratio
for Transmedics Group Inc.

Provide Cash Ratio
for Transmedics Group Inc.

What is the historical Revenue growth
over the last 5 years for Transmedics Group Inc?

What is the historical Net Income growth
over the last 5 years for Transmedics Group Inc?

What is the current Free Cash Flow
of Transmedics Group Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Transmedics Group Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Transmedics Group Inc

Current Assets 492.5m
Cash & Short-Term Investments 330.1m
Receivables 90.1m
Other Current Assets 72.3m
Non-Current Assets 293.1m
PP&E 278.7m
Intangibles 13.8m
Other Non-Current Assets 663k
Current Liabilities 60m
Accounts Payable 13.1m
Accrued Liabilities 44.7m
Other Current Liabilities 2.2m
Non-Current Liabilities 515.6m
Long-Term Debt 508.5m
Other Non-Current Liabilities 7.1m
Efficiency

Earnings Waterfall
Transmedics Group Inc

Revenue
401.1m USD
Cost of Revenue
-163.1m USD
Gross Profit
238m USD
Operating Expenses
-206.5m USD
Operating Income
31.5m USD
Other Expenses
1.2m USD
Net Income
32.6m USD

Free Cash Flow Analysis
Transmedics Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TMDX Profitability Score
Profitability Due Diligence

Transmedics Group Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
44/100
Profitability
Score

Transmedics Group Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

TMDX Solvency Score
Solvency Due Diligence

Transmedics Group Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
64/100
Solvency
Score

Transmedics Group Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TMDX Price Targets Summary
Transmedics Group Inc

Wall Street analysts forecast TMDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMDX is 134.39 USD with a low forecast of 87.87 USD and a high forecast of 189 USD.

Lowest
Price Target
87.87 USD
9% Upside
Average
Price Target
134.39 USD
67% Upside
Highest
Price Target
189 USD
134% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TMDX?

Click here to dive deeper.

Dividends

Transmedics Group Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TMDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TMDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Transmedics Group Inc Logo
Transmedics Group Inc

Country

United States of America

Industry

Health Care

Market Cap

2.7B USD

Dividend Yield

0%

Description

TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 148 full-time employees. The company went IPO on 2019-05-02. The company is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The firm has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.

Contact

MASSACHUSETTS
Andover
200 Minuteman Road
+19785520900.0

IPO

2019-05-02 00:00:00

Employees

148

Officers

Founder, President, CEO & Director
Dr. Waleed H. Hassanein M.D.
CFO, Treasurer & Secretary
Mr. Stephen Gordon
Senior Vice President of Supply Chain & Operations
Mr. Nicholas Corcoran
Senior VP, General Counsel & Corporate Secretary
Mr. Anil Ranganath
Chief Commercial Officer
Dr. Tamer I. Khayal M.D.
Vice President of Global Regulatory Affairs
Ms. Miriam C. Provost Ph.D.

See Also

Discover More
What is the Intrinsic Value of one TMDX stock?

The intrinsic value of one TMDX stock under the Base Case scenario is 46.31 USD.

Is TMDX stock undervalued or overvalued?

Compared to the current market price of 80.61 USD, Transmedics Group Inc is Overvalued by 43%.

Back to Top